Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Peptides and peptide/active compound conjugates for renal targeting

Peptides and peptide/active compound conjugates for renal targeting

US Patent 10065993 · Granted Sep 4, 2018

Estimated economic value: $106,918,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Dielectric copolymer materials2024
Dielectric materials2024
Use of labeled inhibitors of prostate specific membrane antigen (PSMA), as agent2024
Labeled inhibitors of prostate specific membrane antigen (PSMA) as agents for th2024
Lossless cryo-grid preparation by controlled sample evaporation2024
Dielectric copolymer materials2023
Lossless cryo-grid preparation stage for high-resolution electron microscopy2022
Cyclic NTCP-targeting peptides and their uses as entry inhibitors2022
Methylglyoxal-scavenging cyclic peptides and their use for the prevention and tr2021
Labeled inhibitors of prostate specific membrane antigen (PSMA) as agents for th2021
Liposomal formulation for the oral hepatic delivery of drugs2020
CD44v6-derived cyclic peptides for treating cancers and angiogenesis related dis2020